Noninvasive intranasal stem cells and other therapeutic cells bypass the blood-brain barrier to target the CNS to treat Parkinson's disease, stroke, neonatal ischemia, hemorrhage, multiple sclerosis, brain tumors, TBI, Alzheimer's and other CNS disorders
model of multiple sclerosis leading to reduced disease symptoms. Intranasal adult neural stem cells have also been shown to improve the EAE model of MS as having intranasal mesenchymal stromal ... stem cell treatments…

